Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life. Chahin S, Balcer LJ, Miller DM, Zhang A, Galetta SL J Neuroophthalmol. 2014 Nov 3. PMID: 25370598. Abstract CommentRecommendBookmarkWatch